Cargando…
P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EARLY MORTALITY IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS.
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429183/ http://dx.doi.org/10.1097/01.HS9.0000846352.00706.35 |
| _version_ | 1784779358482726912 |
|---|---|
| author | Puła, A. Robak, P. Jarych, D. Mikulski, D. Dróżdż, I. Szemraj, J. Robak, T. |
| author_facet | Puła, A. Robak, P. Jarych, D. Mikulski, D. Dróżdż, I. Szemraj, J. Robak, T. |
| author_sort | Puła, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429183 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94291832022-08-31 P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EARLY MORTALITY IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS. Puła, A. Robak, P. Jarych, D. Mikulski, D. Dróżdż, I. Szemraj, J. Robak, T. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429183/ http://dx.doi.org/10.1097/01.HS9.0000846352.00706.35 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Puła, A. Robak, P. Jarych, D. Mikulski, D. Dróżdż, I. Szemraj, J. Robak, T. P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EARLY MORTALITY IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS. |
| title | P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EARLY MORTALITY IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS. |
| title_full | P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EARLY MORTALITY IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS. |
| title_fullStr | P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EARLY MORTALITY IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS. |
| title_full_unstemmed | P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EARLY MORTALITY IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS. |
| title_short | P868: A CIRCULATING SERUM MIRNAS-BASED MODEL TO PREDICT EARLY MORTALITY IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS. |
| title_sort | p868: a circulating serum mirnas-based model to predict early mortality in multiple myeloma patients treated with bortezomib-based regimens. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429183/ http://dx.doi.org/10.1097/01.HS9.0000846352.00706.35 |
| work_keys_str_mv | AT pułaa p868acirculatingserummirnasbasedmodeltopredictearlymortalityinmultiplemyelomapatientstreatedwithbortezomibbasedregimens AT robakp p868acirculatingserummirnasbasedmodeltopredictearlymortalityinmultiplemyelomapatientstreatedwithbortezomibbasedregimens AT jarychd p868acirculatingserummirnasbasedmodeltopredictearlymortalityinmultiplemyelomapatientstreatedwithbortezomibbasedregimens AT mikulskid p868acirculatingserummirnasbasedmodeltopredictearlymortalityinmultiplemyelomapatientstreatedwithbortezomibbasedregimens AT drozdzi p868acirculatingserummirnasbasedmodeltopredictearlymortalityinmultiplemyelomapatientstreatedwithbortezomibbasedregimens AT szemrajj p868acirculatingserummirnasbasedmodeltopredictearlymortalityinmultiplemyelomapatientstreatedwithbortezomibbasedregimens AT robakt p868acirculatingserummirnasbasedmodeltopredictearlymortalityinmultiplemyelomapatientstreatedwithbortezomibbasedregimens |